See more : Hecla Mining Company (HL) Income Statement Analysis – Financial Results
Complete financial analysis of Kaneka Corporation (KANKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kaneka Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) Income Statement Analysis – Financial Results
- Arima Optoelectronics Corp. (6289.TW) Income Statement Analysis – Financial Results
- Crest Resources Inc. (CRES.CN) Income Statement Analysis – Financial Results
- Copenhagen Capital A/S (CPHCAP-ST.CO) Income Statement Analysis – Financial Results
- Zuleika Gold Limited (ZAG.AX) Income Statement Analysis – Financial Results
Kaneka Corporation (KANKF)
About Kaneka Corporation
Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 762.30B | 755.82B | 691.53B | 577.43B | 601.51B | 621.04B | 596.14B | 548.22B | 555.23B | 552.19B | 524.79B | 476.46B | 469.29B | 453.83B | 412.49B | 449.59B | 502.97B | 473.17B | 464.31B | 438.00B |
Cost of Revenue | 558.09B | 556.90B | 494.88B | 410.49B | 432.37B | 446.25B | 426.96B | 385.36B | 394.02B | 413.39B | 391.99B | 359.73B | 359.54B | 339.38B | 310.25B | 353.18B | 376.03B | 344.52B | 328.51B | 309.20B |
Gross Profit | 204.22B | 198.93B | 196.65B | 166.94B | 169.14B | 174.79B | 169.18B | 162.86B | 161.21B | 138.80B | 132.80B | 116.73B | 109.75B | 114.45B | 102.24B | 96.41B | 126.94B | 128.65B | 135.80B | 128.80B |
Gross Profit Ratio | 26.79% | 26.32% | 28.44% | 28.91% | 28.12% | 28.14% | 28.38% | 29.71% | 29.03% | 25.14% | 25.31% | 24.50% | 23.39% | 25.22% | 24.79% | 21.44% | 25.24% | 27.19% | 29.25% | 29.41% |
Research & Development | 35.40B | 32.67B | 30.89B | 27.82B | 29.39B | 28.96B | 28.04B | 28.51B | 26.77B | 23.32B | 21.10B | 21.38B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 89.61B | 80.46B | 75.51B | 71.89B | 73.51B | 71.11B | 68.18B | 67.63B | 64.10B | 60.90B | 58.00B | 50.95B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 38.79B | 43.40B | 40.47B | 33.65B | 34.35B | 33.30B | 31.47B | 28.69B | 27.87B | 26.42B | 25.42B | 24.34B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 128.40B | 123.86B | 115.97B | 105.54B | 107.86B | 104.41B | 99.65B | 96.31B | 91.97B | 87.32B | 83.42B | 75.29B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 7.84B | -1.67B | -2.98B | -3.62B | -2.83B | -2.73B | 132.29B | -1.41B | -1.96B | -818.00M | -458.00M | -794.00M | -995.00M | -717.00M | -996.00M | -1.15B | -1.29B | 595.00M | 541.00M | -95.00M |
Operating Expenses | 171.64B | 163.84B | 153.09B | 139.40B | 143.12B | 138.75B | 132.29B | 129.70B | 122.99B | 114.16B | 107.98B | 100.92B | 96.59B | 93.21B | 84.73B | 88.80B | 91.19B | 91.99B | 88.20B | 85.67B |
Cost & Expenses | 729.72B | 720.73B | 647.97B | 549.88B | 575.50B | 585.00B | 559.25B | 515.06B | 517.01B | 527.55B | 499.96B | 460.65B | 456.14B | 432.59B | 394.98B | 441.98B | 467.22B | 436.50B | 416.70B | 394.87B |
Interest Income | 224.00M | 222.00M | 178.00M | 97.00M | 138.00M | 146.00M | 107.00M | 87.00M | 59.00M | 117.00M | 65.00M | 63.00M | 116.00M | 121.00M | 146.00M | 253.00M | 307.00M | 304.00M | 173.00M | 179.00M |
Interest Expense | 3.36B | 1.97B | 1.06B | 1.26B | 1.71B | 2.01B | 1.69B | 1.43B | 1.20B | 1.22B | 1.01B | 890.00M | 885.00M | 892.00M | 928.00M | 1.26B | 1.49B | 1.72B | 1.07B | 1.22B |
Depreciation & Amortization | 40.78B | 40.11B | 38.51B | 36.81B | 34.88B | 32.60B | 30.85B | 28.33B | 26.44B | 23.74B | 20.63B | 29.17B | 29.59B | 28.89B | 27.06B | 27.35B | 24.91B | 24.58B | 22.44B | 22.43B |
EBITDA | 80.95B | 74.44B | 75.98B | 60.27B | 56.40B | 66.53B | 63.63B | 58.45B | 58.24B | 53.14B | 37.24B | 44.99B | 42.11B | 49.22B | 42.23B | 27.86B | 57.64B | 58.96B | 68.77B | 61.89B |
EBITDA Ratio | 10.62% | 10.16% | 11.78% | 10.74% | 9.71% | 10.80% | 11.16% | 10.80% | 11.56% | 9.38% | 9.41% | 10.03% | 9.19% | 11.19% | 10.69% | 7.47% | 11.79% | 13.32% | 15.54% | 15.16% |
Operating Income | 32.58B | 35.09B | 43.56B | 27.54B | 26.01B | 36.04B | 36.89B | 33.16B | 38.22B | 24.64B | 24.82B | 15.81B | 13.15B | 21.24B | 17.51B | 7.61B | 35.75B | 36.67B | 47.61B | 43.13B |
Operating Income Ratio | 4.27% | 4.64% | 6.30% | 4.77% | 4.32% | 5.80% | 6.19% | 6.05% | 6.88% | 4.46% | 4.73% | 3.32% | 2.80% | 4.68% | 4.24% | 1.69% | 7.11% | 7.75% | 10.25% | 9.85% |
Total Other Income/Expenses | 4.23B | -2.71B | -7.16B | -5.34B | -6.22B | -4.13B | -5.80B | -4.47B | -7.62B | 3.54B | -9.22B | -879.00M | -1.80B | -1.80B | -2.25B | -8.36B | -4.51B | -4.01B | -2.34B | -4.89B |
Income Before Tax | 36.81B | 32.37B | 36.41B | 22.20B | 19.80B | 31.91B | 31.09B | 28.69B | 30.60B | 28.17B | 15.60B | 14.93B | 11.35B | 19.44B | 15.25B | -754.00M | 31.24B | 32.66B | 45.27B | 38.24B |
Income Before Tax Ratio | 4.83% | 4.28% | 5.26% | 3.84% | 3.29% | 5.14% | 5.21% | 5.23% | 5.51% | 5.10% | 2.97% | 3.13% | 2.42% | 4.28% | 3.70% | -0.17% | 6.21% | 6.90% | 9.75% | 8.73% |
Income Tax Expense | 12.03B | 8.30B | 8.68B | 5.02B | 4.32B | 7.93B | 8.29B | 7.18B | 9.59B | 9.60B | 1.35B | 5.45B | 5.47B | 6.78B | 5.95B | 888.00M | 11.94B | 13.66B | 16.74B | 13.13B |
Net Income | 23.22B | 23.01B | 26.49B | 15.83B | 14.00B | 22.24B | 21.57B | 20.48B | 20.99B | 18.03B | 13.65B | 9.33B | 5.40B | 11.63B | 8.41B | -1.85B | 18.82B | 18.36B | 28.10B | 24.75B |
Net Income Ratio | 3.05% | 3.04% | 3.83% | 2.74% | 2.33% | 3.58% | 3.62% | 3.74% | 3.78% | 3.27% | 2.60% | 1.96% | 1.15% | 2.56% | 2.04% | -0.41% | 3.74% | 3.88% | 6.05% | 5.65% |
EPS | 356.87 | 349.59 | 406.00 | 242.68 | 214.69 | 339.14 | 328.45 | 308.60 | 314.90 | 267.60 | 202.50 | 138.40 | 79.80 | 171.40 | 123.90 | -27.22 | 275.50 | 267.40 | 404.00 | 353.25 |
EPS Diluted | 356.87 | 348.66 | 404.96 | 242.13 | 214.28 | 338.59 | 328.05 | 308.25 | 314.60 | 267.40 | 202.35 | 138.25 | 79.75 | 171.30 | 123.85 | -27.22 | 275.45 | 267.40 | 404.00 | 346.65 |
Weighted Avg Shares Out | 65.07M | 65.82M | 65.24M | 65.23M | 65.22M | 65.57M | 65.68M | 66.38M | 66.64M | 67.39M | 67.40M | 67.39M | 67.69M | 67.82M | 67.85M | 67.97M | 68.30M | 68.67M | 69.21M | 69.66M |
Weighted Avg Shares Out (Dil) | 65.07M | 65.99M | 65.39M | 65.36M | 65.33M | 65.68M | 65.76M | 66.45M | 66.70M | 67.44M | 67.46M | 67.45M | 67.74M | 67.86M | 67.87M | 67.97M | 68.31M | 68.67M | 69.21M | 71.38M |
Source: https://incomestatements.info
Category: Stock Reports